[Goodpasture's syndrome].
Nojima
Y
Y
Third Department of Internal Medicine, Gunma University School of Medicine.
D019867:Anti-Glomerular Basement Membrane Disease / Q000209:etiology / Q000503:physiopathology; D000906:Antibodies / Q000276:immunology; D001323:Autoantibodies; D001324:Autoantigens / Q000276:immunology; D018932:Chemokine CCL2 / Q000378:metabolism; D003094:Collagen / Q000276:immunology; D024141:Collagen Type IV; D003937:Diagnosis, Differential; D000939:Epitopes; D006684:HLA-DR Antigens / Q000235:genetics; D059811:HLA-DRB1 Chains; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D011379:Prognosis
D000906:Antibodies; D001323:Autoantibodies; D001324:Autoantigens; D018932:Chemokine CCL2; D024141:Collagen Type IV; D000939:Epitopes; D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; D007166:Immunosuppressive Agents; C051951:antiglomerular basement membrane antibody; C057112:type IV collagen alpha3 chain; D003094:Collagen